Dean Y. Li - Jan 3, 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 07:46 PM
Previous filing
Dec 9, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +659 +0.11% $0.00 598K Jan 3, 2022 Direct F1
holding RXRX Class A Common Stock 1.32M Jan 3, 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.32M Jan 3, 2022 By Dean Y. Li 2021 GRAT
holding RXRX Class A Common Stock 1.42M Jan 3, 2022 By Dean Li and Ruth Li Revocable Trust
holding RXRX Class A Common Stock 450K Jan 3, 2022 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.